Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Type 1 Diabetes examining aerobic and resistance exercise (T1-DARE) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED